METTL3/YTHDF1 m6 一个轴通过增强卵巢癌中的DDR2表达来促进瘤发生
Duo Zhi1, Kun Zhou2, Shuang Liu1
1Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, China.
Pathology, research and practice
|December 28, 2023
概括
METTL3/YTHDF1 N6-甲基氨酸 (m6A) 轴通过增加瘤促进物 DDR2.2 来促进卵巢癌的进展. 针对这一轴可以为卵巢癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 卵巢癌在妇科恶性瘤中表现出高死亡率.
- N6-甲基氨酸 (m6A) 修饰是各种癌症的关键调节剂,但其在卵巢癌中的作用尚不清楚.
研究的目的:
- 阐明m6A修饰途径在卵巢癌进展中的作用.
- 为了确定卵巢癌治疗的潜在治疗点.
主要方法:
- 在卵巢癌中研究了METTL3/YTHDF1 m6A轴.
- 评估了METTL3/YTHDF1耗尽对癌症扩散和转移的 in vitro 和 in vivo 影响.
- 研究了METTL3/YTHDF1轴与DDR2mRNA之间的相互作用.
主要成果:
- 减少METTL3/YTHDF1显著损害了卵巢癌细胞的扩散和转移.
- 发现METTL3/YTHDF1 m6A轴直接与DDR2 mRNA结合.
- 这种相互作用促进了DDR2的表达,DDR2是卵巢癌中已知的瘤促进剂.
结论:
- METTL3/YTHDF1/DDR2 m6A轴对卵巢癌的进展至关重要.
- 这一途径代表了卵巢癌治疗的潜在治疗标.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.8K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.9K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
